Medical News

RSS

Ascent Healthcare Solutions to reprocess the SoundStar 3D Diagnostic Ultrasound Catheter

Ascent Healthcare Solutions, a leader in delivering healthcare resource sustainability, today announced that it has received the industry’s first and only 510(k) clearance from the U.S. Food and Drug Administration (FDA) to reprocess the Biosense Webster SoundStar™ 3D Diagnostic Ultrasound Catheter. With this new clearance, Ascent continues to lead the charge in bringing sustainability to healthcare.

28 Oct 2009

Veeva CRM to be implemented at Adamas Pharmaceuticals

Adamas Pharmaceuticals, an emerging pharmaceutical company focused on developing small-molecule therapeutics to treat neurological and infectious diseases, selected Veeva System’s VBioPharma™ KOL Edition – part of the Veeva CRM suite. Selection of Veeva’s SaaS solution marks an important step in Adamas’ early-stage product commercialization strategy.

28 Oct 2009

Arrayit sells NanoPrint Microarrayer system to CENAT

Arrayit Corporation today announced the sale of a system to the Center of Excellence for Nucleic Acid-Based Technologies (CENAT) in Poznan, Poland. The Arrayit NanoPrint Microarrayer will be used by CENAT for scientific and medical collaborations throughout the prosperous democracy.

28 Oct 2009

New CCS guidelines and position papers for physicians and nurse practitioners

Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week.

28 Oct 2009

Third-quarter fiscal 2009 results announced by Life Quotes

Life Quotes, Inc., the only place on earth where you can get auto, life, health, home and business insurance quotes from over 100 leading companies and have the freedom to buy from the company of your choice, today announced financial results for the third quarter ended September 30, 2009.

28 Oct 2009

Auxilium Pharmaceuticals reports increased net revenues of $42.1 million in third quarter 2009

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended September 30, 2009. For the third quarter of 2009, Auxilium reported net revenues of $42.1 million compared to net revenues of $32.6 million in the third quarter of 2008.

28 Oct 2009

Scientists test rapamycin's effectiveness at rescuing impaired nerve cells

Johns Hopkins scientists report having used a commercially available drug to successfully "rescue" animal brain cells that they had intentionally damaged by manipulating a newly discovered gene that links susceptibility genes for schizophrenia and autism.

28 Oct 2009

Rural Oregons in poverty face tough choices between eating well and spending less money for meals

A new study by Oregon State University researchers shows that those in poverty in rural Oregon often know what kinds of foods they should be eating, but face tough choices between eating well and spending less money for meals.

28 Oct 2009

In healthcare fraud prevention, public sector leads the charge

MarketResearch.com has announced the addition of Datamonitor's new report, "Running in the Never-ending Race Against Healthcare Fraud (Strategic Focus)," to their collection of Healthcare market reports.

28 Oct 2009

NSF awards $3 million grant for establishing a Partnership in Research and Education in Materials

Professor Morris is principal investigator on a new, five-year $3 million National Science Foundation (NSF) grant that establishes a Partnership in Research and Education in Materials (PREM) at CCNY in collaboration with the University of Chicago's Materials Research Science and Engineering Center. The "overarching goal of the partnership is to develop methodology for description of material dynamics" as an emerging branch of materials science.

28 Oct 2009

Total number of vertebrae: Hox genes have a say

Vertebrates have in common a skeleton made of segments, the vertebrae. During development of the embryo, each segment is added in a time dependent manner, from the head-end to the tail-end: the first segments to be added become the vertebrae of the neck, later segments become the vertebrae with ribs and the last ones the vertebra located in the tail (in the case of a mouse, for example). In this process, it is crucial that, on the one hand, each segment, as it matures, becomes the correct type of vertebra and, on the other, that the number of vertebrae in the skeleton, and therefore the size of the spine, are minutely controlled.

28 Oct 2009

Veterans with TBI vision loss have poor quality of life compared to civilian patients

Pan-American Association of Ophthalmology (PAAO) Joint Meeting, includes a Veterans Administration study that indicates that Iraq and Afghanistan veterans with vision loss from traumatic brain injury have significantly poorer quality of life than comparable civilian patients, and a Harvard doctor's insights on how to best evaluate and care for low-vision patients who experience vivid visual hallucinations due to Charles Bonnet syndrome.

28 Oct 2009

NMHIC appointed as New Mexico's official health information exchange

Maggie Gunter, PhD, president of the New Mexico Health Information Collaborative (NMHIC), announced today that the organization has been appointed as the state's official health information exchange (HIE) by New Mexico Governor Bill Richardson.

28 Oct 2009

NYPNU serves a 10-day strike notice to Lenox Hill Hospital

The New York Professional Nurses Union (NYPNU) members voted overwhelmingly to strike at Lenox Hill Hospital and Manhattan Eye, Ear and Throat Hospital. Today, NYPNU has served Gladys George, President/CEO of Lenox Hill Hospital, with a 10-day strike notice and set a strike deadline of Monday, November 9.

28 Oct 2009

Amgen to reduce price of Neulasta following Board's orders

The Board issued a Notice of Hearing on March 16, 2009, pertaining to allegations of Board Staff that Neulasta had been, and was being, sold by Amgen Canada Inc. at prices exceeding those indicated by the Board's Excessive Price Guidelines. On October 13, 2009, the Hearing Panel received a Joint Submission by Amgen and Board Staff along with a Voluntary Compliance Undertaking ("VCU") which proposed to resolve the issues raised in the Neulasta proceedings.

28 Oct 2009

Urigen Pharmaceuticals announces a presentation on interstitial cystitis/painful bladder syndrome

Urigen Pharmaceuticals, Inc., focused on the development of treatments for urologic disorders and pain, announces a presentation at its offices on October 30, 2009 at 2PM PST. The slides presented will be posted to its website at www.urigen.com after the close of trading that day.

28 Oct 2009

Provisions in health care bill may transform nation's largest abortion chain into quasi-government status

The Senate version of America's Healthy Future Act of 2009 may transform the nation's largest abortion chain into a quasi-government entity for sex education.

28 Oct 2009

UHC: Implementation of patient- and family-centered care improves quality of care for patients

Understanding the needs of patients and their families has several advantages for health care providers, including enhancing safety and helping to stem the increasing costs of medical errors and malpractice litigation. In fact, many academic medical centers are turning to implementation of patient- and family-centered care (PFCC) to improve the quality of care for patients.

28 Oct 2009

First Edition: October 28, 2009

The news of the day again seems to focus on Senate Democrat's public option as well as the politics, strong-arming and vote-counting that it has caused.

28 Oct 2009

Deloitte releases "Acquisitions versus Product Development: An Emerging Trend in Life Sciences" report

Recent pharmaceutical mergers and acquisitions indicate a trend of consolidation in the industry. Companies are looking for ways to bolster their research and development pipelines and reduce costs by rationalizing their combined sales and reducing other corporate overhead.

28 Oct 2009

Medical News

Ascent Healthcare Solutions to reprocess the SoundStar 3D Diagnostic Ultrasound Catheter

Veeva CRM to be implemented at Adamas Pharmaceuticals

Arrayit sells NanoPrint Microarrayer system to CENAT

New CCS guidelines and position papers for physicians and nurse practitioners

Third-quarter fiscal 2009 results announced by Life Quotes

Auxilium Pharmaceuticals reports increased net revenues of $42.1 million in third quarter 2009

Scientists test rapamycin's effectiveness at rescuing impaired nerve cells

Rural Oregons in poverty face tough choices between eating well and spending less money for meals

In healthcare fraud prevention, public sector leads the charge

NSF awards $3 million grant for establishing a Partnership in Research and Education in Materials

Total number of vertebrae: Hox genes have a say

Veterans with TBI vision loss have poor quality of life compared to civilian patients

NMHIC appointed as New Mexico's official health information exchange

NYPNU serves a 10-day strike notice to Lenox Hill Hospital

Amgen to reduce price of Neulasta following Board's orders

Urigen Pharmaceuticals announces a presentation on interstitial cystitis/painful bladder syndrome

Provisions in health care bill may transform nation's largest abortion chain into quasi-government status

UHC: Implementation of patient- and family-centered care improves quality of care for patients

First Edition: October 28, 2009

Deloitte releases "Acquisitions versus Product Development: An Emerging Trend in Life Sciences" report

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News